Align Technology Inc (ALGN)
Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell
$156.15
Buy
$158.08
$-3.75 (-2.32%)
Prices updated at 20 Dec 2025, 00:12 EST
| Prices minimum 15 mins delay
Prices in USD
Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2023 | 2024 |
|---|---|---|
| 3,862m | 3,999m | |
| 2,707m | 2,799m | |
| 657m | 672m | |
| 17.00 | 16.80 | |
| 445m | 421m | |
| 799m | 817m | |
| Sales, General and administrative | 1,703m | 1,763m |
| Interest expenses | - | - |
| Provision for income taxes | 196m | 188m |
| Operating expenses | 2,050m | 2,127m |
| Income before taxes | 641m | 609m |
| Net income available to common shareholders | 445m | 421m |
| 5.82 | 5.63 | |
| Net interest income | 17m | 20m |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 5.81 | 5.62 |
| Free cash flow per share | 8.9023 | 4.9542 |
| Book value/share | 50.6409 | 53.4111 |
| Debt equity ratio | 0.026709 | 0.022901 |
Balance sheet
Year | 2023 | 2024 |
|---|---|---|
| Current assets | 2,447m | 2,492m |
| Current liabilities | 2,067m | 2,038m |
| Total capital | 3,630m | 3,852m |
| Total debt | 127m | 119m |
| Total equity | 3,630m | 3,852m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 6,084m | 6,215m |
| Total liabilities | - | - |
| Cash and cash equivalents | 937m | 1,044m |
| Common stock | 75m | 74m |
Cash flow
Year | 2023 | 2024 |
|---|---|---|
| Cash at beginning of period | 942m | 939m |
| Cash dividends paid | - | - |
| 608m | 623m | |
| Investments (gains) losses | -196m | -255m |
| 939m | 1,045m | |
| Net income | - | - |
| 786m | 738m | |
| -178m | -116m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.